Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis

Gut

Volumn 63, Issue 2, 2014, Pages 281-291

  Johansson, Malin E V ^a   Gustafsson, Jenny K ^a   Holmen Larsson, Jessica ^a   Jabbar, Karolina S ^a   Xia, Lijun ^b   Xu, Hua ^c   Ghishan, Fayez K ^c   Carvalho, Frederic A ^d   Gewirtz, Andrew T ^d   Sjovall, Henrik ^a   Hansson, Gunnar C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 2;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MEMBRANE PERMEABILITY; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGMOID; ULCERATIVE COLITIS; WILD TYPE; YOUNG ADULT;

EID: 84891736162     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303207     Document Type: Article

References (38)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34. (Pubitemid 47123518)
2. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33. (Pubitemid 38649878)
3. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474:307-17.
4. Danese S, Fiocchi C. Ulcerative Colitis. New Engl J Med 2011;365:1713-25.
5. Schirbel A, Fiocchi C. Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 2010;11:266-76.
6. Johansson MEV, Hansson GC. Keeping Bacteria at a Distance. Science 2011;334:182-3.
7. Johansson MEV, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 2008;105:15064-9.
8. Van der Waaij LA, Harmsen HJM, Madjipour M, et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 2005;11:865-71. (Pubitemid 41428844)
9. Swidsinski A, Loening-Baucke V, Lochs H, et al. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 2005;11:1131-40. (Pubitemid 40352998)
10. Matsuo K, Ota H, Akamatsu T, et al. Histochemistry of the surface mucous gel layer of the human colon. Gut 1997;40:782-9. (Pubitemid 27305472)
11. Johansson MEV, Larsson JM Holmen, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA 2011;108:4659-65.
12. Godl K, Johansson MEV, Karlsson H, et al. The N-termini of the MUC2 mucin form trimers that are held together within a trypsin-resistant core fragment. J Biol Chem 2002;277:47248-56. (Pubitemid 36163373)
13. Ambort D, Johansson MEV, Gustafsson JK, et al. Calcium and pH-dependent packing and release of the Gel-forming MUC2 Mucin. Proc Natl Acad Sci USA 2012;109:5645-50.
14. Johansson MEV, Thomsson KA, Hansson GC. Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the FCGBP protein. J Proteome Res 2009;8:3549-57.
15. Van der SM, De Koning BA, De Bruijn AC, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006;131:117-29. (Pubitemid 44015753)
16. Swidsinski A, Loening-Baucke V, Theissig F, et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007;56:343-50. (Pubitemid 46579762)
17. Schultsz C, Van Den Berg FM, En Kate FW, et al. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999;117:1089-97. (Pubitemid 29512667)
18. Johansson MEV, Gustafsson JK, Sjoberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the Dextran sulfate colitis model. PLoS ONE 2010;5:e12238.
19. Gustafsson JK, Ermund A, Johansson MEV, et al. An ex vivo method for studying mucus formation, properties and thickness in human colonic biopsies and mouse small and large intestinal explants. Amer J Physiol Gastrointest Liver Physiol 2011;302:G430-8.
20. Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008;14:1660-6.
21. Fu J, Wei B, Wen T, et al. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis. J Clin Invest 2011;121:1657-66.
22. Schultheis PJ, Clarke LL, Meneton P, et al. Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat Genet 1998;19:282-5. (Pubitemid 28309344)
23. Laubitz D, Larmonier CB, Bai A, et al. Colonic gene expression profile in NHE3-deficient mice: evidence for spontaneous distal colitis. Am J Physiol Gastrointest Liver Physiol 2008;295:G63-77.
24. Isao O, Shigeru H, Masahiro Y, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
25. Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007;117:3909-21. (Pubitemid 350224100)
26. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74. (Pubitemid 23320290)
27. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31. (Pubitemid 29044613)
28. Yan Y, Kolachala V, Dalmasso G, et al. Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced Colitis. PLoS ONE 2009;4:e6073.
29. Carvalho FA, Koren O, Goodrich JK, et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 2012;12:139-52.
30. Izcue A, Coombes JL, Powrie F. Regulatory Lymphocytes and Intestinal Inflammation. Annu Rev Immunol 2009;27:313-38.
31. Hoshi N, Schenten D, Nish SA, et al. MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice. Nat Commun 2012;3:1120.
32. Gustafsson JK, Ermund A, Ambort D, et al. Bicarbonate and functional CFTR channel is required for proper mucin secretion and link Cystic Fibrosis with its mucus phenotype. J Exp Med 2012;209:1263-72.
33. Mannon PJ, Hornung RL, Yang Z, et al. Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production. Gut 2011;60:449-55.
34. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205. (Pubitemid 28307304)
35. Gilat T, Leichtman G, Delpre G, et al. A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis. J Clin Gastroenterol 1989;11:392-5. (Pubitemid 19202397)
36. Gionchetti P, Rizzello F, Ferrieri A, et al. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. Dig Dis Sci 1999;44:1220-1. (Pubitemid 29297232)
37. Johansson MEV, Ambort D, Pelaseyed T, et al. Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 2011;68:3535-641.
38. Grootjans J, Hundscheild IH, Lenaerts K, et al. Ischemia-induced mucus barrier loss and bacterial penetration are rapidly counteracted by increased goblet cell secretory activity in human and rat colon. Gut 2012;62:250-8.